Abstract
Cardiovascular diseases (CVDs) are a large group of diseases and have become the leading cause of morbidity and mortality worldwide. Although considerable progresses have been made in the diagnosis, treatment and prognosis of CVD, communication barriers between clinicians and researchers still exist because the phenotypes of CVD are complex and diverse in clinical practice and lack of unity. Therefore, it is particularly important to establish a standardized and unified terminology to describe CVD. In recent years, there have been several studies, such as the Human Phenotype Ontology, attempting to provide a standardized description of the disease phenotypes. In the present article, we outline recent advances in the classification of the major types of CVD to retrospectively review the current progresses of phenotypic studies in the cardiovascular field and provide a reference for future cardiovascular research.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
(1980) Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J 44:672–3. https://doi.org/10.1136/hrt.44.6.672
Abela GS, Vedre A, Janoudi A, Huang R, Durga S, Tamhane U (2011) Effect of statins on cholesterol crystallization and atherosclerotic plaque stabilization. Am J Cardiol 107:1710–1717. https://doi.org/10.1016/j.amjcard.2011.02.336
Allanson JE, Biesecker LG, Carey JC, Hennekam RC (2009) Elements of morphology: introduction. Am J Med Genet A 149A:2–5. https://doi.org/10.1002/ajmg.a.32601
Andelfinger G, Loeys B, Dietz H (2016) A decade of discovery in the genetic understanding of thoracic aortic disease. Can J Cardiol 32:13–25. https://doi.org/10.1016/j.cjca.2015.10.017
Andrabi S, Bekheirnia MR, Robbins-Furman P, Lewis RA, Prior TW, Potocki L (2011) SMAD4 mutation segregating in a family with juvenile polyposis, aortopathy, and mitral valve dysfunction. Am J Med Genet A 155A:1165–1169. https://doi.org/10.1002/ajmg.a.33968
Andreassi MG, Della Corte A (2016) Genetics of bicuspid aortic valve aortopathy. Curr Opin Cardiol 31:585–592. https://doi.org/10.1097/HCO.0000000000000328
Angelini A, Ho SY, Anderson RH, Devine WA, Zuberbuhler JR, Becker AE, Davies MJ (1989) The morphology of the normal aortic valve as compared with the aortic valve having two leaflets. J Thorac Cardiovasc Surg 98:362–367
Antman EM, Loscalzo J (2016) Precision medicine in cardiology. Nat Rev Cardiol 13:591–602. https://doi.org/10.1038/nrcardio.2016.101
Attenhofer Jost CH, Connolly HM, Dearani JA, Edwards WD, Danielson GK (2007) Ebstein’s anomaly. Circulation 115:277–285. https://doi.org/10.1161/CIRCULATIONAHA.106.619338
Atzinger CL, Meyer RA, Khoury PR, Gao Z, Tinkle BT (2011) Cross-sectional and longitudinal assessment of aortic root dilation and valvular anomalies in hypermobile and classic Ehlers-Danlos syndrome. J Pediatr 158:826-830 e1. https://doi.org/10.1016/j.jpeds.2010.11.023
Baasanjav S, Al-Gazali L, Hashiguchi T, Mizumoto S, Fischer B, Horn D, Seelow D, Ali BR, Aziz SA, Langer R, Saleh AA, Becker C, Nurnberg G, Cantagrel V, Gleeson JG, Gomez D, Michel JB, Stricker S, Lindner TH, Nurnberg P, Sugahara K, Mundlos S, Hoffmann K (2011) Faulty initiation of proteoglycan synthesis causes cardiac and joint defects. Am J Hum Genet 89:15–27. https://doi.org/10.1016/j.ajhg.2011.05.021
Bilder RM, Sabb FW, Cannon TD, London ED, Jentsch JD, Parker DS, Poldrack RA, Evans C, Freimer NB (2009) Phenomics: the systematic study of phenotypes on a genome-wide scale. Neuroscience 164:30–42. https://doi.org/10.1016/j.neuroscience.2009.01.027
Bozkurt B, Coats AJS, Tsutsui H, Abdelhamid CM, Adamopoulos S, Albert N, Anker SD, Atherton J, Bohm M, Butler J, Drazner MH, Michael Felker G, Filippatos G, Fiuzat M, Fonarow GC, Gomez-Mesa JE, Heidenreich P, Imamura T, Jankowska EA, Januzzi J, Khazanie P, Kinugawa K, Lam CSP, Matsue Y, Metra M, Ohtani T, Francesco Piepoli M, Ponikowski P, Rosano GMC, Sakata Y, Seferovic P, Starling RC, Teerlink JR, Vardeny O, Yamamoto K, Yancy C, Zhang J, Zieroth S (2021) Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association. Eur J Heart Fail 23:352–380. https://doi.org/10.1002/ejhf.2115
Bull MJ (2020) Down syndrome. N Engl J Med 382:2344–2352. https://doi.org/10.1056/NEJMra1706537
Carpentier A (1983) Cardiac valve surgery–the “French correction.” J Thorac Cardiovasc Surg 86:323–337
Carpentier A, Chauvaud S, Mace L, Relland J, Mihaileanu S, Marino JP, Abry B, Guibourt P (1988) A new reconstructive operation for Ebstein’s anomaly of the tricuspid valve. J Thorac Cardiovasc Surg 96:92–101
Celermajer DS, Bull C, Till JA, Cullen S, Vassillikos VP, Sullivan ID, Allan L, Nihoyannopoulos P, Somerville J, Deanfield JE (1994) Ebstein’s anomaly: presentation and outcome from fetus to adult. J Am Coll Cardiol 23:170–176. https://doi.org/10.1016/0735-1097(94)90516-9
Chauvaud S, Berrebi A, d’Attellis N, Mousseaux E, Hernigou A, Carpentier A (2003) Ebstein’s anomaly: repair based on functional analysis. Eur J Cardiothorac Surg 23:525–531. https://doi.org/10.1016/s1010-7940(02)00836-9
Chen L, Song J, Chen X, Chen K, Ren J, Zhang N, Rao M, Hu Z, Zhang Y, Gu M, Zhao H, Tang H, Yang Z, Hu S (2019) A novel genotype-based clinicopathology classification of arrhythmogenic cardiomyopathy provides novel insights into disease progression. Eur Heart J 40:1690–1703. https://doi.org/10.1093/eurheartj/ehz172
Crawford ES, Snyder DM, Cho GC, Roehm JO Jr (1978) Progress in treatment of thoracoabdominal and abdominal aortic aneurysms involving celiac, superior mesenteric, and renal arteries. Ann Surg 188:404–422. https://doi.org/10.1097/00000658-197809000-00016
Crawford ES, Crawford JL, Safi HJ, Coselli JS, Hess KR, Brooks B, Norton HJ, Glaeser DH (1986) Thoracoabdominal aortic aneurysms: preoperative and intraoperative factors determining immediate and long-term results of operations in 605 patients. J Vasc Surg 3:389–404. https://doi.org/10.1067/mva.1986.avs0030389
Crawford ES, Svensson LG, Coselli JS, Safi HJ, Hess KR (1989) Surgical treatment of aneurysm and/or dissection of the ascending aorta, transverse aortic arch, and ascending aorta and transverse aortic arch. Factors influencing survival in 717 patients. J Thorac Cardiovasc Surg 98:659–673
Crea F, Libby P (2017) Acute coronary syndromes: the way forward from mechanisms to precision treatment. Circulation 136:1155–1166. https://doi.org/10.1161/CIRCULATIONAHA.117.029870
Cripe L, Andelfinger G, Martin LJ, Shooner K, Benson DW (2004) Bicuspid aortic valve is heritable. J Am Coll Cardiol 44:138–143. https://doi.org/10.1016/j.jacc.2004.03.050
Dadson K, Hauck L, Billia F (2017) Molecular mechanisms in cardiomyopathy. Clin Sci (lond) 131:1375–1392. https://doi.org/10.1042/CS20160170
Daily PO, Trueblood HW, Stinson EB, Wuerflein RD, Shumway NE (1970) Management of acute aortic dissections. Ann Thorac Surg 10:237–247. https://doi.org/10.1016/s0003-4975(10)65594-4
de Kerchove L, Mastrobuoni S, Froede L, Tamer S, Boodhwani M, van Dyck M, El Khoury G, Schafers HJ (2019) Variability of repairable bicuspid aortic valve phenotypes: towards an anatomical and repair-oriented classification. Eur J Cardiothorac Surg. https://doi.org/10.1093/ejcts/ezz033
Debakey ME, Henly WS, Cooley DA, Morris GC Jr, Crawford ES, Beall AC Jr (1965) Surgical management of dissecting aneurysms of the aorta. J Thorac Cardiovasc Surg 49:130–149
DeBakey ME, McCollum CH, Crawford ES, Morris GC Jr, Howell J, Noon GP, Lawrie G (1982) Dissection and dissecting aneurysms of the aorta: twenty-year follow-up of five hundred twenty-seven patients treated surgically. Surgery 92:1118–1134
Del Pasqua A, Rinelli G, Toscano A, Iacobelli R, Digilio C, Marino B, Saffirio C, Mondillo S, Pasquini L, Sanders SP, de Zorzi A (2009) New findings concerning cardiovascular manifestations emerging from long-term follow-up of 150 patients with the Williams-Beuren-Beuren syndrome. Cardiol Young 19:563–567. https://doi.org/10.1017/S1047951109990837
Delling FN, Rong J, Larson MG, Lehman B, Fuller D, Osypiuk E, Stantchev P, Hackman B, Manning WJ, Benjamin EJ, Levine RA, Vasan RS (2016) Evolution of mitral valve prolapse: insights from the framingham heart study. Circulation 133:1688–1695. https://doi.org/10.1161/CIRCULATIONAHA.115.020621
Detaint D, Faivre L, Collod-Beroud G, Child AH, Loeys BL, Binquet C, Gautier E, Arbustini E, Mayer K, Arslan-Kirchner M, Stheneur C, Halliday D, Beroud C, Bonithon-Kopp C, Claustres M, Plauchu H, Robinson PN, Kiotsekoglou A, De Backer J, Ades L, Francke U, De Paepe A, Boileau C, Jondeau G (2010) Cardiovascular manifestations in men and women carrying a FBN1 mutation. Eur Heart J 31:2223–2229. https://doi.org/10.1093/eurheartj/ehq258
Durst R, Sauls K, Peal DS, deVlaming A, Toomer K, Leyne M, Salani M, Talkowski ME, Brand H, Perrocheau M, Simpson C, Jett C, Stone MR, Charles F, Chiang C, Lynch SN, Bouatia-Naji N, Delling FN, Freed LA, Tribouilloy C, Le Tourneau T, LeMarec H, Fernandez-Friera L, Solis J, Trujillano D, Ossowski S, Estivill X, Dina C, Bruneval P, Chester A, Schott JJ, Irvine KD, Mao Y, Wessels A, Motiwala T, Puceat M, Tsukasaki Y, Menick DR, Kasiganesan H, Nie X, Broome AM, Williams K, Johnson A, Markwald RR, Jeunemaitre X, Hagege A, Levine RA, Milan DJ, Norris RA, Slaugenhaupt SA (2015) Mutations in DCHS1 cause mitral valve prolapse. Nature 525:109–113. https://doi.org/10.1038/nature14670
Elliott PM (2013) Classification of cardiomyopathies: evolution or revolution? J Am Coll Cardiol 62:2073–2074. https://doi.org/10.1016/j.jacc.2013.10.008
Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kuhl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A (2008) Classification of the cardiomyopathies: a position statement from the European society of cardiology working group on myocardial and pericardial diseases. Eur Heart J 29:270–276. https://doi.org/10.1093/eurheartj/ehm342
Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, Tillmanns C, Watkins H (2014) 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 35:2733–2779. https://doi.org/10.1093/eurheartj/ehu284
Erbel R, Alfonso F, Boileau C, Dirsch O, Eber B, Haverich A, Rakowski H, Struyven J, Radegran K, Sechtem U, Taylor J, Zollikofer C, Klein WW, Mulder B, Providencia LA, Task Force on Aortic Dissection, E. S. o. C (2001) Diagnosis and management of aortic dissection. Eur Heart J 22:1642–1681. https://doi.org/10.1053/euhj.2001.2782
Fonarow GC (2017) Refining classification of heart failure based on ejection fraction. JACC Heart Fail 5:808–809. https://doi.org/10.1016/j.jchf.2017.08.011
Freed LA, Levy D, Levine RA, Larson MG, Evans JC, Fuller DL, Lehman B, Benjamin EJ (1999) Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med 341:1–7. https://doi.org/10.1056/NEJM199907013410101
Freimer N, Sabatti C (2003) The human phenome project. Nat Genet 34:15–21. https://doi.org/10.1038/ng0503-15
Galea J, Ellul S, Schembri A, Schembri-Wismayer P, Calleja-Agius J (2014) Ebstein anomaly: a review. Neonatal Netw 33:268–274. https://doi.org/10.1891/0730-0832.33.5.268
Gaur S, Ovrehus KA, Dey D, Leipsic J, Botker HE, Jensen JM, Narula J, Ahmadi A, Achenbach S, Ko BS, Christiansen EH, Kaltoft AK, Berman DS, Bezerra H, Lassen JF, Norgaard BL (2016) Coronary plaque quantification and fractional flow reserve by coronary computed tomography angiography identify ischaemia-causing lesions. Eur Heart J 37:1220–1227. https://doi.org/10.1093/eurheartj/ehv690
Ge J (2020) Coding proposal on phenotyping heart failure with preserved ejection fraction: a practical tool for facilitating etiology-oriented therapy. Cardiol J 27:97–98. https://doi.org/10.5603/CJ.2020.0023
Geske JB, Ommen SR, Gersh BJ (2018) Hypertrophic cardiomyopathy: clinical update. JACC Heart Fail 6:364–375. https://doi.org/10.1016/j.jchf.2018.02.010
Guy TS, Hill AC (2012) Mitral valve prolapse. Annu Rev Med 63:277–292. https://doi.org/10.1146/annurev-med-022811-091602
Hall HN, Williamson KA, FitzPatrick DR (2019) The genetic architecture of aniridia and Gillespie syndrome. Hum Genet 138:881–898. https://doi.org/10.1007/s00439-018-1934-8
Hinton RB, Martin LJ, Rame-Gowda S, Tabangin ME, Cripe LH, Benson DW (2009) Hypoplastic left heart syndrome links to chromosomes 10q and 6q and is genetically related to bicuspid aortic valve. J Am Coll Cardiol 53:1065–1071. https://doi.org/10.1016/j.jacc.2008.12.023
Hirst AE Jr, Johns VJ Jr, Kime SW Jr (1958) Dissecting aneurysm of the aorta: a review of 505 cases. Med (baltim) 37:217–279. https://doi.org/10.1097/00005792-195809000-00003
Hoffman JI, Kaplan S (2002) The incidence of congenital heart disease. J Am Coll Cardiol 39:1890–1900. https://doi.org/10.1016/s0735-1097(02)01886-7
Hortop J, Tsipouras P, Hanley JA, Maron BJ, Shapiro JR (1986) Cardiovascular involvement in osteogenesis imperfecta. Circulation 73:54–61. https://doi.org/10.1161/01.cir.73.1.54
Jia H, Dai J, Hou J, Xing L, Ma L, Liu H, Xu M, Yao Y, Hu S, Yamamoto E, Lee H, Zhang S, Yu B, Jang IK (2017) Effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion (the EROSION study). Eur Heart J 38:792–800. https://doi.org/10.1093/eurheartj/ehw381
Jilaihawi H, Chen M, Webb J, Himbert D, Ruiz CE, Rodes-Cabau J, Pache G, Colombo A, Nickenig G, Lee M, Tamburino C, Sievert H, Abramowitz Y, Tarantini G, Alqoofi F, Chakravarty T, Kashif M, Takahashi N, Kazuno Y, Maeno Y, Kawamori H, Chieffo A, Blanke P, Dvir D, Ribeiro HB, Feng Y, Zhao ZG, Sinning JM, Kliger C, Giustino G, Pajerski B, Imme S, Grube E, Leipsic J, Vahanian A, Michev I, Jelnin V, Latib A, Cheng W, Makkar R (2016) A bicuspid aortic valve imaging classification for the TAVR era. JACC Cardiovasc Imaging 9:1145–1158. https://doi.org/10.1016/j.jcmg.2015.12.022
Jondeau G, Ropers J, Regalado E, Braverman A, Evangelista A, Teixedo G, De Backer J, Muino-Mosquera L, Naudion S, Zordan C, Morisaki T, Morisaki H, Von Kodolitsch Y, Dupuis-Girod S, Morris SA, Jeremy R, Odent S, Ades LC, Bakshi M, Holman K, LeMaire S, Milleron O, Langeois M, Spentchian M, Aubart M, Boileau C, Pyeritz R, Milewicz DM, Montalcino Aortic C (2016) International registry of patients carrying TGFBR1 or TGFBR2 mutations: results of the MAC (Montalcino Aortic Consortium). Circ Cardiovasc Genet 9:548–558. https://doi.org/10.1161/CIRCGENETICS.116.001485
Le Tourneau T, Le Scouarnec S, Cueff C, Bernstein D, Aalberts JJJ, Lecointe S, Merot J, Bernstein JA, Oomen T, Dina C, Karakachoff M, Desal H, Al Habash O, Delling FN, Capoulade R, Suurmeijer AJH, Milan D, Norris RA, Markwald R, Aikawa E, Slaugenhaupt SA, Jeunemaitre X, Hagege A, Roussel JC, Trochu JN, Levine RA, Kyndt F, Probst V, Le Marec H, Schott JJ (2018a) New insights into mitral valve dystrophy: a Filamin-A genotype-phenotype and outcome study. Eur Heart J 39:1269–1277. https://doi.org/10.1093/eurheartj/ehx505
Le Tourneau T, Merot J, Rimbert A, Le Scouarnec S, Probst V, Le Marec H, Levine RA, Schott JJ (2018b) Genetics of syndromic and non-syndromic mitral valve prolapse. Heart 104:978–984. https://doi.org/10.1136/heartjnl-2017-312420
Lee B, Godfrey M, Vitale E, Hori H, Mattei MG, Sarfarazi M, Tsipouras P, Ramirez F, Hollister DW (1991) Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. Nature 352:330–334. https://doi.org/10.1038/352330a0
Leopold JA, Loscalzo J (2018) Emerging role of precision medicine in cardiovascular disease. Circ Res 122:1302–1315. https://doi.org/10.1161/CIRCRESAHA.117.310782
Libby P (2015) Triglycerides on the rise: should we swap seats on the seesaw? Eur Heart J 36:774–776. https://doi.org/10.1093/eurheartj/ehu500
Loeys BL, Chen J, Neptune ER, Judge DP, Podowski M, Holm T, Meyers J, Leitch CC, Katsanis N, Sharifi N, Xu FL, Myers LA, Spevak PJ, Cameron DE, De Backer J, Hellemans J, Chen Y, Davis EC, Webb CL, Kress W, Coucke P, Rifkin DB, De Paepe AM, Dietz HC (2005) A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 37:275–281. https://doi.org/10.1038/ng1511
Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, De Backer JF, Oswald GL, Symoens S, Manouvrier S, Roberts AE, Faravelli F, Greco MA, Pyeritz RE, Milewicz DM, Coucke PJ, Cameron DE, Braverman AC, Byers PH, De Paepe AM, Dietz HC (2006) Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 355:788–798. https://doi.org/10.1056/NEJMoa055695
Mangold A, Alias S, Scherz T, Hofbauer T, Jakowitsch J, Panzenbock A, Simon D, Laimer D, Bangert C, Kammerlander A, Mascherbauer J, Winter MP, Distelmaier K, Adlbrecht C, Preissner KT, Lang IM (2015) Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size. Circ Res 116:1182–1192. https://doi.org/10.1161/CIRCRESAHA.116.304944
Maron BJ (1997) Hypertrophic cardiomyopathy. Lancet 350:127–133. https://doi.org/10.1016/S0140-6736(97)01282-8
Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH 3rd, Spirito P, Ten Cate FJ, Wigle ED (2003) American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J 24:1965–1991. https://doi.org/10.1016/s0195-668x(03)00479-2
Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB, American Heart A, Council on Clinical Cardiology HF, Transplantation C, Quality of C, Outcomes R, Functional G, Translational Biology Interdisciplinary Working G, Council on E and Prevention (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113:1807–1816. https://doi.org/10.1161/CIRCULATIONAHA.106.174287
Martinez-Legazpi P, Bermejo J, Benito Y, Yotti R, Perez Del Villar C, Gonzalez-Mansilla A, Barrio A, Villacorta E, Sanchez PL, Fernandez-Aviles F, del Alamo JC (2014) Contribution of the diastolic vortex ring to left ventricular filling. J Am Coll Cardiol 64:1711–1721. https://doi.org/10.1016/j.jacc.2014.06.1205
Meschini V, Mittal R, Verzicco R (2021) Systolic anterior motion in hypertrophic cardiomyopathy: a fluid–structure interaction computational model. Theoret Comput Fluid Dyn. https://doi.org/10.1007/s00162-021-00564-0
Meuwese MC, de Groot E, Duivenvoorden R, Trip MD, Ose L, Maritz FJ, Basart DC, Kastelein JJ, Habib R, Davidson MH, Zwinderman AH, Schwocho LR, Stein EA, Investigators C (2009) ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial. JAMA 301:1131–1139. https://doi.org/10.1001/jama.301.11.1131
Morton AC, Rothman AM, Greenwood JP, Gunn J, Chase A, Clarke B, Hall AS, Fox K, Foley C, Banya W, Wang D, Flather MD, Crossman DC (2015) The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study. Eur Heart J 36:377–384. https://doi.org/10.1093/eurheartj/ehu272
Muchtar E, Blauwet LA, Gertz MA (2017) Restrictive cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ Res 121:819–837. https://doi.org/10.1161/CIRCRESAHA.117.310982
Ng SB, Turner EH, Robertson PD, Flygare SD, Bigham AW, Lee C, Shaffer T, Wong M, Bhattacharjee A, Eichler EE, Bamshad M, Nickerson DA, Shendure J (2009) Targeted capture and massively parallel sequencing of 12 human exomes. Nature 461:272–276. https://doi.org/10.1038/nature08250
Peterss S, Mansour AM, Ross JA, Vaitkeviciute I, Charilaou P, Dumfarth J, Fang H, Ziganshin BA, Rizzo JA, Adeniran AJ, Elefteriades JA (2016) Changing pathology of the thoracic aorta from acute to chronic dissection: literature review and insights. J Am Coll Cardiol 68:1054–1065. https://doi.org/10.1016/j.jacc.2016.05.091
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Authors/Task force M., and Document, R (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18:891–975. https://doi.org/10.1002/ejhf.592
Prakash SK, Bosse Y, Muehlschlegel JD, Michelena HI, Limongelli G, Della Corte A, Pluchinotta FR, Russo MG, Evangelista A, Benson DW, Body SC, Milewicz DM, Investigators BA (2014) A roadmap to investigate the genetic basis of bicuspid aortic valve and its complications: insights from the International BAVCon (Bicuspid Aortic Valve Consortium). J Am Coll Cardiol 64:832–839. https://doi.org/10.1016/j.jacc.2014.04.073
Prakash SK, Bondy CA, Maslen CL, Silberbach M, Lin AE, Perrone L, Limongelli G, Michelena HI, Bossone E, Citro R, Bavcon Investigators GRI, Lemaire SA, Body SC, Milewicz DM (2016) Autosomal and X chromosome structural variants are associated with congenital heart defects in Turner syndrome: The NHLBI GenTAC registry. Am J Med Genet A 170:3157–3164. https://doi.org/10.1002/ajmg.a.37953
Prunier F, Terrien G, Le Corre Y, Apana AL, Biere L, Kauffenstein G, Furber A, Bergen AA, Gorgels TG, Le Saux O, Leftheriotis G, Martin L (2013) Pseudoxanthoma elasticum: cardiac findings in patients and Abcc6-deficient mouse model. PLoS ONE 8:e68700. https://doi.org/10.1371/journal.pone.0068700
Putnam AJ, Kebed K, Mor-Avi V, Rashedi N, Sun D, Patel B, Balkhy H, Lang RM, Patel AR (2020) Prevalence of mitral annular disjunction in patients with mitral valve prolapse and severe regurgitation. Int J Cardiovasc Imaging 36:1363–1370. https://doi.org/10.1007/s10554-020-01818-4
Reul GJ, Cooley DA, Hallman GL, Reddy SB, Kyger ER 3rd, Wukasch DC (1975) Dissecting aneurysm of the descending aorta. Improved surgical results in 91 patients. Arch Surg 110:632–640. https://doi.org/10.1001/archsurg.1975.01360110178030
Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O’Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P (1996) Report of the 1995 World Health Organization/International society and federation of cardiology task force on the definition and classification of cardiomyopathies. Circulation 93:841–842. https://doi.org/10.1161/01.cir.93.5.841
Roberts WC (1970) The congenitally bicuspid aortic valve. A study of 85 autopsy cases. Am J Cardiol 26:72–83. https://doi.org/10.1016/0002-9149(70)90761-7
Roman MJ, Devereux RB, Kramer-Fox R, Spitzer MC (1989) Comparison of cardiovascular and skeletal features of primary mitral valve prolapse and Marfan syndrome. Am J Cardiol 63:317–321. https://doi.org/10.1016/0002-9149(89)90338-x
Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, Ahmed M, Aksut B, Alam T, Alam K, Alla F, Alvis-Guzman N, Amrock S, Ansari H, Arnlov J, Asayesh H, Atey TM, Avila-Burgos L, Awasthi A, Banerjee A, Barac A, Barnighausen T, Barregard L, Bedi N, Belay Ketema E, Bennett D, Berhe G, Bhutta Z, Bitew S, Carapetis J, Carrero JJ, Malta DC, Castaneda-Orjuela CA, Castillo-Rivas J, Catala-Lopez F, Choi JY, Christensen H, Cirillo M, Cooper L Jr, Criqui M, Cundiff D, Damasceno A, Dandona L, Dandona R, Davletov K, Dharmaratne S, Dorairaj P, Dubey M, Ehrenkranz R, El Sayed Zaki M, Faraon EJA, Esteghamati A, Farid T, Farvid M, Feigin V, Ding EL, Fowkes G, Gebrehiwot T, Gillum R, Gold A, Gona P, Gupta R, Habtewold TD, Hafezi-Nejad N, Hailu T, Hailu GB, Hankey G, Hassen HY, Abate KH, Havmoeller R, Hay SI, Horino M, Hotez PJ, Jacobsen K, James S, Javanbakht M, Jeemon P, John D, Jonas J, Kalkonde Y, Karimkhani C, Kasaeian A, Khader Y, Khan A, Khang YH, Khera S, Khoja AT, Khubchandani J, Kim D, Kolte D, Kosen S, Krohn KJ, Kumar GA, Kwan GF, Lal DK, Larsson A, Linn S, Lopez A, Lotufo PA, El Razek HMA et al (2017) Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol 70:1–25. https://doi.org/10.1016/j.jacc.2017.04.052
Rubegni P, Mondillo S, De Aloe G, Agricola E, Bardelli AM, Fimiani M (2000) Mitral valve prolapse in healthy relatives of patients with familial Pseudoxanthoma elasticum. Am J Cardiol 85:1268–1271. https://doi.org/10.1016/s0002-9149(00)00745-1
Sabet HY, Edwards WD, Tazelaar HD, Daly RC (1999) Congenitally bicuspid aortic valves: a surgical pathology study of 542 cases (1991 through 1996) and a literature review of 2,715 additional cases. Mayo Clin Proc 74:14–26. https://doi.org/10.4065/74.1.14
Safi HJ (1999) How I do it: thoracoabdominal aortic aneurysm graft replacement. Cardiovasc Surg 7:607–613. https://doi.org/10.1016/s0967-2109(99)00039-3
Schepers D, Tortora G, Morisaki H, MacCarrick G, Lindsay M, Liang D, Mehta SG, Hague J, Verhagen J, van de Laar I, Wessels M, Detisch Y, van Haelst M, Baas A, Lichtenbelt K, Braun K, van der Linde D, Roos-Hesselink J, McGillivray G, Meester J, Maystadt I, Coucke P, El-Khoury E, Parkash S, Diness B, Risom L, Scurr I, Hilhorst-Hofstee Y, Morisaki T, Richer J, Desir J, Kempers M, Rideout AL, Horne G, Bennett C, Rahikkala E, Vandeweyer G, Alaerts M, Verstraeten A, Dietz H, Van Laer L, Loeys B (2018) A mutation update on the LDS-associated genes TGFB2/3 and SMAD2/3. Hum Mutat 39:621–634. https://doi.org/10.1002/humu.23407
Schuster SC (2008) Next-generation sequencing transforms today’s biology. Nat Methods 5:16–18. https://doi.org/10.1038/nmeth1156
Schweizer PA, Schroter J, Greiner S, Haas J, Yampolsky P, Mereles D, Buss SJ, Seyler C, Bruehl C, Draguhn A, Koenen M, Meder B, Katus HA, Thomas D (2014) The symptom complex of familial sinus node dysfunction and myocardial noncompaction is associated with mutations in the HCN4 channel. J Am Coll Cardiol 64:757–767. https://doi.org/10.1016/j.jacc.2014.06.1155
Shah AM, Pfeffer MA (2012) The many faces of heart failure with preserved ejection fraction. Nat Rev Cardiol 9:555–556. https://doi.org/10.1038/nrcardio.2012.123
Shah PK, Chyu KY, Dimayuga PC, Nilsson J (2014a) Vaccine for atherosclerosis. J Am Coll Cardiol 64:2779–2791. https://doi.org/10.1016/j.jacc.2014.10.018
Shah SJ, Katz DH, Deo RC (2014b) Phenotypic spectrum of heart failure with preserved ejection fraction. Heart Fail Clin 10:407–418. https://doi.org/10.1016/j.hfc.2014.04.008
Sievers HH, Schmidtke C (2007) A classification system for the bicuspid aortic valve from 304 surgical specimens. J Thorac Cardiovasc Surg 133:1226–1233. https://doi.org/10.1016/j.jtcvs.2007.01.039
Siu SC, Silversides CK (2010) Bicuspid aortic valve disease. J Am Coll Cardiol 55:2789–2800. https://doi.org/10.1016/j.jacc.2009.12.068
Tang X, Chen W, Zeng Z, Ding K, Zhou Z (2020) An ontology-based classification of Ebstein’s anomaly and its implications in clinical adverse outcomes. Int J Cardiol 316:79–86. https://doi.org/10.1016/j.ijcard.2020.04.073
Triposkiadis F, Butler J, Abboud FM, Armstrong PW, Adamopoulos S, Atherton JJ, Backs J, Bauersachs J, Burkhoff D, Bonow RO, Chopra VK, de Boer RA, de Windt L, Hamdani N, Hasenfuss G, Heymans S, Hulot JS, Konstam M, Lee RT, Linke WA, Lunde IG, Lyon AR, Maack C, Mann DL, Mebazaa A, Mentz RJ, Nihoyannopoulos P, Papp Z, Parissis J, Pedrazzini T, Rosano G, Rouleau J, Seferovic PM, Shah AM, Starling RC, Tocchetti CG, Trochu JN, Thum T, Zannad F, Brutsaert DL, Segers VF, De Keulenaer GW (2019) The continuous heart failure spectrum: moving beyond an ejection fraction classification. Eur Heart J 40:2155–2163. https://doi.org/10.1093/eurheartj/ehz158
Urbanski PP, Wagner M (2016) Acute non-A-non-B aortic dissection: surgical or conservative approach? Eur J Cardiothorac Surg 49:1249–1254. https://doi.org/10.1093/ejcts/ezv301
van de Laar IM, Oldenburg RA, Pals G, Roos-Hesselink JW, de Graaf BM, Verhagen JM, Hoedemaekers YM, Willemsen R, Severijnen LA, Venselaar H, Vriend G, Pattynama PM, Collee M, Majoor-Krakauer D, Poldermans D, Frohn-Mulder IM, Micha D, Timmermans J, Hilhorst-Hofstee Y, Bierma-Zeinstra SM, Willems PJ, Kros JM, Oei EH, Oostra BA, Wessels MW, Bertoli-Avella AM (2011) Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nat Genet 43:121–126. https://doi.org/10.1038/ng.744
van de Laar IM, van der Linde D, Oei EH, Bos PK, Bessems JH, Bierma-Zeinstra SM, van Meer BL, Pals G, Oldenburg RA, Bekkers JA, Moelker A, de Graaf BM, Matyas G, Frohn-Mulder IM, Timmermans J, Hilhorst-Hofstee Y, Cobben JM, Bruggenwirth HT, van Laer L, Loeys B, De Backer J, Coucke PJ, Dietz HC, Willems PJ, Oostra BA, De Paepe A, Roos-Hesselink JW, Bertoli-Avella AM, Wessels MW (2012) Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome. J Med Genet 49:47–57. https://doi.org/10.1136/jmedgenet-2011-100382
van der Linde D, van de Laar IM, Bertoli-Avella AM, Oldenburg RA, Bekkers JA, Mattace-Raso FU, van den Meiracker AH, Moelker A, van Kooten F, Frohn-Mulder IM, Timmermans J, Moltzer E, Cobben JM, van Laer L, Loeys B, De Backer J, Coucke PJ, De Paepe A, Hilhorst-Hofstee Y, Wessels MW, Roos-Hesselink JW (2012) Aggressive cardiovascular phenotype of aneurysms-osteoarthritis syndrome caused by pathogenic SMAD3 variants. J Am Coll Cardiol 60:397–403. https://doi.org/10.1016/j.jacc.2011.12.052
Van Praagh S, Truman T, Firpo A, Bano-Rodrigo A, Fried R, McManus B, Engle MA, Van Praagh R (1989) Cardiac malformations in trisomy-18: a study of 41 postmortem cases. J Am Coll Cardiol 13:1586–1597. https://doi.org/10.1016/0735-1097(89)90353-7
Verdonschot JAJ, Merlo M, Dominguez F, Wang P, Henkens M, Adriaens ME, Hazebroek MR, Mase M, Escobar LE, Cobas-Paz R, Derks KWJ, van den Wijngaard A, Krapels IPC, Brunner HG, Sinagra G, Garcia-Pavia P, Heymans SRB (2020) Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences. Eur Heart J. https://doi.org/10.1093/eurheartj/ehaa841
Wang J, Wang Y, Zou Y, Sun K, Wang Z, Ding H, Yuan J, Wei W, Hou Q, Wang H, Liu X, Zhang H, Ji Y, Zhou X, Sharma RK, Wang D, Ahmad F, Hui R, Song L (2014) Malignant effects of multiple rare variants in sarcomere genes on the prognosis of patients with hypertrophic cardiomyopathy. Eur J Heart Fail 16:950–957. https://doi.org/10.1002/ejhf.144
Yagi H, Furutani Y, Hamada H, Sasaki T, Asakawa S, Minoshima S, Ichida F, Joo K, Kimura M, Imamura S, Kamatani N, Momma K, Takao A, Nakazawa M, Shimizu N, Matsuoka R (2003) Role of TBX1 in human del22q11.2 syndrome. Lancet 362:1366–1373. https://doi.org/10.1016/s0140-6736(03)14632-6
Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W, Li X, Wang L, Wang L, Liu Y, Liu J, Zhang M, Qi J, Yu S, Afshin A, Gakidou E, Glenn S, Krish VS, Miller-Petrie MK, Mountjoy-Venning WC, Mullany EC, Redford SB, Liu H, Naghavi M, Hay SI, Wang L, Murray CJL, Liang X (2019) Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 394:1145–1158. https://doi.org/10.1016/S0140-6736(19)30427-1
Zimmer S, Grebe A, Bakke SS, Bode N, Halvorsen B, Ulas T, Skjelland M, De Nardo D, Labzin LI, Kerksiek A, Hempel C, Heneka MT, Hawxhurst V, Fitzgerald ML, Trebicka J, Bjorkhem I, Gustafsson JA, Westerterp M, Tall AR, Wright SD, Espevik T, Schultze JL, Nickenig G, Lutjohann D, Latz E (2016) Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming. Sci Transl Med 8:333ra50. https://doi.org/10.1126/scitranslmed.aad6100
Funding
This study was supported by Shanghai Municipal Science and Technology Major Project (2017SHZDZX01).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors claim no conflicts of interests.
Availability of data and material
Not applicable.
Code availability
Not applicable.
Author contributions
HZ performed the literature survey and wrote the manuscript, XH corrected the manuscript, JS provided the theme and guided the manuscript writing.
Ethics approval
Not applicable.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Rights and permissions
About this article
Cite this article
Zhang, H., Hua, X. & Song, J. Phenotypes of Cardiovascular Diseases: Current Status and Future Perspectives. Phenomics 1, 229–241 (2021). https://doi.org/10.1007/s43657-021-00022-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43657-021-00022-1